Andrew S Judd

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick B Brady, Bryan K Sorensen, Roberto M Risi, Michael L Curtin, Robert A Mantei, Alan S Florjancic, Anthony Mastracchio, Cheng Ji, Aaron R Kunzer, Chunqiu Lai, Gregory E Storer, Vincent S Chan, Rodger F Henry, Andrew J Souers, Michael R Michaelides, Andrew S Judd, T Matthew Hansen
Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467. The Journal of organic chemistry (2023)
Wen-Ju Bai, Michelle A Estrada, Jackson A Gartman, Andrew S Judd
Enantioselective Bioreduction of Medicinally Relevant Nitrogen-Heteroaromatic Ketones. ACS medicinal chemistry letters 14 (6) (2023)
Zhi-Fu Tao, Xilu Wang, Jun Chen, Justin P Ingram, Sha Jin, Russell A Judge, Peter J Kovar, Chang Park, Chaohong Sun, Brian D Wakefield, Li Zhou, Haichao Zhang, Steven W Elmore, Darren C Phillips, Andrew S Judd, Joel D Leverson, Andrew J Souers
Structure-Based Design of A-1293102, a Potent and Selective BCL-XL Inhibitor. ACS medicinal chemistry letters 12 (6) (2021)

Andrew S Judd.css-eqlu8i{font-size:small;padding-left:4px;}